Key result
Cardiac contractility modulation therapy had a beneficial effect on survival and quality of life in patients with chronic heart failure and normal QRS duration.
Why the study?
Does cardiac contractility modulation improve outcomes in patients with chronic heart failure with low ejection fraction and normal QRS duration?
Population
617 patients with chronic heart failure with low ejection fraction, normal QRS duration, and NYHA class II…
Design
Review
Authors
Loading...
May support CCM consideration in non-CRT HF patients; leaves open need for randomized confirmation.
Does cardiac contractility modulation improve outcomes in patients with chronic heart failure with low ejection fraction and normal QRS duration?
Cardiac contractility modulation appears to improve survival and quality of life in heart failure patients with low ejection fraction and normal QRS duration who are not candidates for cardiac resynchronization therapy.
Петрухина et al. (2016) conducted a review in Chronic heart failure with low ejection fraction (n=617). Cardiac contractility modulation (CCM) vs. Optimal medical therapy was evaluated on Survival and quality of life. Cardiac contractility modulation therapy had a beneficial effect on survival and quality of life in patients with chronic heart failure and normal QRS duration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: